These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 28461331)
21. Dysregulation of Sirtuin 2 (SIRT2) and histone H3K18 acetylation pathways associates with adverse prostate cancer outcomes. Damodaran S; Damaschke N; Gawdzik J; Yang B; Shi C; Allen GO; Huang W; Denu J; Jarrard D BMC Cancer; 2017 Dec; 17(1):874. PubMed ID: 29262808 [TBL] [Abstract][Full Text] [Related]
22. Design, synthesis, and biological activity of a novel series of human sirtuin-2-selective inhibitors. Suzuki T; Khan MN; Sawada H; Imai E; Itoh Y; Yamatsuta K; Tokuda N; Takeuchi J; Seko T; Nakagawa H; Miyata N J Med Chem; 2012 Jun; 55(12):5760-73. PubMed ID: 22642300 [TBL] [Abstract][Full Text] [Related]
23. SIRT2: Controversy and multiple roles in disease and physiology. Wang Y; Yang J; Hong T; Chen X; Cui L Ageing Res Rev; 2019 Nov; 55():100961. PubMed ID: 31505260 [TBL] [Abstract][Full Text] [Related]
24. Modulation Of Microtubule Acetylation By The Interplay Of TPPP/p25, SIRT2 And New Anticancer Agents With Anti-SIRT2 Potency. Szabó A; Oláh J; Szunyogh S; Lehotzky A; Szénási T; Csaplár M; Schiedel M; Lőw P; Jung M; Ovádi J Sci Rep; 2017 Dec; 7(1):17070. PubMed ID: 29213065 [TBL] [Abstract][Full Text] [Related]
25. Deacetylation of phosphoglycerate mutase in its distinct central region by SIRT2 down-regulates its enzymatic activity. Tsusaka T; Guo T; Yagura T; Inoue T; Yokode M; Inagaki N; Kondoh H Genes Cells; 2014 Oct; 19(10):766-77. PubMed ID: 25195573 [TBL] [Abstract][Full Text] [Related]
26. SIRT2 regulates oxidative stress-induced cell death through deacetylation of c-Jun NH Sarikhani M; Mishra S; Desingu PA; Kotyada C; Wolfgeher D; Gupta MP; Singh M; Sundaresan NR Cell Death Differ; 2018 Sep; 25(9):1638-1656. PubMed ID: 29449643 [TBL] [Abstract][Full Text] [Related]
27. Infection Reveals a Modification of SIRT2 Critical for Chromatin Association. Pereira JM; Chevalier C; Chaze T; Gianetto Q; Impens F; Matondo M; Cossart P; Hamon MA Cell Rep; 2018 Apr; 23(4):1124-1137. PubMed ID: 29694890 [TBL] [Abstract][Full Text] [Related]
28. SUMOylation is essential for Sirt2 tumor-suppressor function in neuroblastoma. Lu W; Wang Q; Xu C; Yuan H; Fan Q; Chen B; Cai R; Wu D; Xu M Neoplasia; 2021 Jan; 23(1):129-139. PubMed ID: 33316537 [TBL] [Abstract][Full Text] [Related]
29. Sirtuin 2 Isoform 1 Enhances Hepatitis B Virus RNA Transcription and DNA Synthesis through the AKT/GSK-3β/β-Catenin Signaling Pathway. Piracha ZZ; Kwon H; Saeed U; Kim J; Jung J; Chwae YJ; Park S; Shin HJ; Kim K J Virol; 2018 Nov; 92(21):. PubMed ID: 30111572 [TBL] [Abstract][Full Text] [Related]
30. Insight into the Mechanism of Intramolecular Inhibition of the Catalytic Activity of Sirtuin 2 (SIRT2). Li J; Flick F; Verheugd P; Carloni P; Lüscher B; Rossetti G PLoS One; 2015; 10(9):e0139095. PubMed ID: 26407304 [TBL] [Abstract][Full Text] [Related]
31. SIRT2 suppresses expression of inflammatory factors via Hsp90-glucocorticoid receptor signalling. Sun K; Wang X; Fang N; Xu A; Lin Y; Zhao X; Nazarali AJ; Ji S J Cell Mol Med; 2020 Jul; 24(13):7439-7450. PubMed ID: 32515550 [TBL] [Abstract][Full Text] [Related]
33. Design, synthesis and structure-activity relationship studies of novel sirtuin 2 (SIRT2) inhibitors with a benzamide skeleton. Sakai T; Matsumoto Y; Ishikawa M; Sugita K; Hashimoto Y; Wakai N; Kitao A; Morishita E; Toyoshima C; Hayashi T; Akiyama T Bioorg Med Chem; 2015 Jan; 23(2):328-39. PubMed ID: 25515955 [TBL] [Abstract][Full Text] [Related]
34. Active nuclear import of the deacetylase Sirtuin-2 is controlled by its C-terminus and importins. Eldridge MJG; Pereira JM; Impens F; Hamon MA Sci Rep; 2020 Feb; 10(1):2034. PubMed ID: 32042025 [TBL] [Abstract][Full Text] [Related]
35. SIRT2 modulates VEGFD-associated lymphangiogenesis by deacetylating EPAS1 in human head and neck cancer. Hu A; Yang LY; Liang J; Lu D; Zhang JL; Cao FF; Fu JY; Dai WJ; Zhang JF Mol Carcinog; 2020 Nov; 59(11):1280-1291. PubMed ID: 32965071 [TBL] [Abstract][Full Text] [Related]
36. AK-1, a SIRT2 inhibitor, destabilizes HIF-1α and diminishes its transcriptional activity during hypoxia. Lee SD; Kim W; Jeong JW; Park JW; Kim JE Cancer Lett; 2016 Apr; 373(1):138-145. PubMed ID: 26808575 [TBL] [Abstract][Full Text] [Related]
37. NOTCH-induced aldehyde dehydrogenase 1A1 deacetylation promotes breast cancer stem cells. Zhao D; Mo Y; Li MT; Zou SW; Cheng ZL; Sun YP; Xiong Y; Guan KL; Lei QY J Clin Invest; 2014 Dec; 124(12):5453-65. PubMed ID: 25384215 [TBL] [Abstract][Full Text] [Related]
38. Discovery of New SIRT2 Inhibitors by Utilizing a Consensus Docking/Scoring Strategy and Structure-Activity Relationship Analysis. Huang S; Song C; Wang X; Zhang G; Wang Y; Jiang X; Sun Q; Huang L; Xiang R; Hu Y; Li L; Yang S J Chem Inf Model; 2017 Apr; 57(4):669-679. PubMed ID: 28301150 [TBL] [Abstract][Full Text] [Related]
39. The role of SIRT2 in cancer: A novel therapeutic target. Chen G; Huang P; Hu C Int J Cancer; 2020 Dec; 147(12):3297-3304. PubMed ID: 32449165 [TBL] [Abstract][Full Text] [Related]
40. X-ray crystal structure guided discovery of new selective, substrate-mimicking sirtuin 2 inhibitors that exhibit activities against non-small cell lung cancer cells. Yang LL; Wang HL; Zhong L; Yuan C; Liu SY; Yu ZJ; Liu S; Yan YH; Wu C; Wang Y; Wang Z; Yu Y; Chen Q; Li GB Eur J Med Chem; 2018 Jul; 155():806-823. PubMed ID: 29957526 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]